Nanobodies as allosteric modulators of Parkinson's disease-associated LRRK2.
Singh RK, Soliman A, Guaitoli G, Störmer E, von Zweydorf F, Dal Maso T, Oun A, Van Rillaer L, Schmidt SH, Chatterjee D, David JA, Pardon E, Schwartz TU, Knapp S, Kennedy EJ, Steyaert J, Herberg FW, Kortholt A, Gloeckner CJ, Versées W.
Singh RK, et al. Among authors: stormer e.
Proc Natl Acad Sci U S A. 2022 Mar 1;119(9):e2112712119. doi: 10.1073/pnas.2112712119.
Proc Natl Acad Sci U S A. 2022.
PMID: 35217606
Free PMC article.